Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 2, 2006 Stephen D. Simpson	Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note.
The Motley Fool May 9, 2005 Stephen D. Simpson	Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point.
The Motley Fool February 21, 2007 Rich Duprey	Foolish Forecast: Adding to Integra LifeSciences The med-tech company is set to report fourth-quarter 2006 earnings. Investors, here is what you can expect to see.
The Motley Fool March 6, 2006 Stephen D. Simpson	Integra Integrates Higher Revenue High rewards will match high expectations -- if the medical device company delivers. Investors, take note.
The Motley Fool May 25, 2006 Stephen D. Simpson	Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business.
The Motley Fool August 8, 2005 Stephen D. Simpson	Shedding a Little Light on Rofin-Sinar Valuations on this small-cap laser company are modest, but so are expectations.
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
The Motley Fool July 27, 2011	Integra LifeSciences Holdings Earnings Preview Integra LifeSciences Holdings will unveil its latest earnings Thursday.
The Motley Fool April 17, 2008 Anders Bylund	Foolish Forecast: Intuitive Surgical Is Worth Every Penny In advance of earnings, let's compare robotic-surgery equipment manufacturer Intuitive Surgical to some of its peers and competitors.
The Motley Fool February 3, 2006 Stephen D. Simpson	Phase 2 for Intuitive Surgical Now that the initial rush is over, it's time for Intuitive Surgical to build a lasting business. Investors need to be careful with this one.
The Motley Fool August 24, 2005 Stephen D. Simpson	Sweet Air Around ResMed Growing awareness of breathing problems in sleep continues to fuel robust growth at the company. But with a fairly high valuation already in place, these shares aren't a recommended buy.
The Motley Fool March 1, 2007	Sewing Up Integra Lifesciences: Fool by Numbers The medical-device specialist released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool August 18, 2005 Stephen D. Simpson	Kensey Nash Needs to Kick It Up The med-tech company must deliver profit growth if it is to grow or maintain its valuation.
The Motley Fool July 27, 2006 Stephen D. Simpson	Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space.
The Motley Fool July 25, 2006 Nathan Parmelee	Wrigley's Chewed-Up Performance Wrigley's quarter isn't impressive, but this is a business that will endure. The valuation isn't terribly attractive here, because there isn't much of a margin of safety if growth ends up being slightly slower than it has been historically.
The Motley Fool January 5, 2006 Stephen D. Simpson	Constellation's Growth Going Flat? Organic growth in wine and spirits fizzled a bit, but cash flow continues to pour in. Though it doesn't look like a value at this price, it's certainly one to keep watching.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
The Motley Fool April 22, 2005 Stephen D. Simpson	Success Is Intuitive Surgical robotics continues to grow, and Intuitive Surgical dominates the market. It's important to note, though, that valuation is a tricky matter when you're dealing with fast-growing companies that are basically pioneering entirely new businesses.
The Motley Fool February 24, 2009 Brian Orelli	Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day.
The Motley Fool June 22, 2006 Seth Jayson	Family Dollar Still No Bargain Another quarter, another minor earnings surprise for low-budget retailer Family Dollar. The business is fine, but investors, why pay full price?
The Motley Fool January 30, 2006 Stephen D. Simpson	A Bard's Tale The advanced medical technology company's stock already reflects new products' potential. Still, life in the med-tech sector could get more interesting in the coming quarters. Investors, take note.
The Motley Fool October 19, 2005 Stephen D. Simpson	ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note.
The Motley Fool March 6, 2009 Brian Orelli	Why the Buyback, Intuitive Surgical? Buybacks for high-growth companies like Intuitive Surgical aren't such a bad idea anymore.
The Motley Fool June 20, 2006 Ryan Fuhrmann	It's 80/20 at ITW Will Illinois Tool Works' recent gains continue? Overall, cyclical companies are hard to recommend as long-term buy-and-hold investments.
The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool April 19, 2006 Stephen D. Simpson	St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note.
The Motley Fool July 27, 2006 Nathan Parmelee	Is Anheuser-Busch Turning the Corner? Anheuser-Busch's performance is an improvement over last year's, but there is still a way to go before the company matches some of its better performances. Investors, take note.
The Motley Fool February 26, 2004 Dave Marino-Nachison	Engineered Support's System Solid profit margins and successful acquisitions are helping the military contractor grow.
The Motley Fool March 23, 2006 Stephen D. Simpson	CLARCOR's "S.O.L.": Strong Operating Leverage Modest revenue growth becomes strong bottom-line growth for this filtration supplier. However, the stock has had a pretty nice run and no longer looks all that cheap.
The Motley Fool July 28, 2005 Mike Cianciolo	Stanley Works Acquires Its Way to Growth The nation's leading toolmaker continues to build solid growth. The company projects full-year earnings of $3.20 to $3.30 per diluted share, which would represent an increase of 12% to 16% over last year's earnings.
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool August 11, 2006 Stephen D. Simpson	Waiting for Liberty Global to Get Its Due This growing European cable operator increasingly looks like a value. Investors, take note.
The Motley Fool February 13, 2006 Stephen D. Simpson	ResMed Might Need Oxygen Like its cousin Respironics, this company suffers from an all-too-common fate in med-tech land: It's a great company trading at a not-so-great price.
The Motley Fool March 6, 2006 Stephen D. Simpson	Integrating Integra's Numbers: Fool by Numbers Integra LifeSciences released fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool August 24, 2011 Brian Orelli	Growth, but Not Great Growth Medtronic's growth comes with lower margins.
The Motley Fool August 21, 2006 Stephen D. Simpson	Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
The Motley Fool June 20, 2005 Richard Gibbons	Think Like a Dealmaker Acquisitions can be great for investors. Here's how to identify acquisition targets before deals are announced.
The Motley Fool April 20, 2006 Stephen D. Simpson	More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter.
The Motley Fool December 11, 2006 Jack Uldrich	Intuitive Surgical's Beating Heart Investors, there are a lot of reasons to like Intuitive Surgical. Better software will continue to improve surgeons' performance levels in meeting the demanding requirements of cardiovascular surgery.
The Motley Fool February 4, 2011 Seth Jayson	Does Edwards Lifesciences Measure Up? With recent TTM operating margins exceeding historical averages, Edwards Lifesciences looks like it's doing fine.
The Motley Fool July 25, 2007 Billy Fisher	Dueling Fools: Intuitive Surgical Bull For a company consistently growing its sales by 50% and maintaining healthy product margins, it's hard to imagine that this medical device maker's stock has yet met its peak.
The Motley Fool August 30, 2005 Nathan Parmelee	Is Electronics Boutique's Strategy Sound? The video game software and hardware retailer shows revenue growth, but profits don't follow the same trend. Are the acquisitions worth it? Investors, take note.
The Motley Fool November 3, 2006	Integra's Improving Revenues: Fool by Numbers Integra LifeSciences released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool May 8, 2006 Stephen D. Simpson	Integra Adds Another Piece The jigsaw puzzle gets larger at Integra Lifesciences, but does it get better? Investors, this company has treated its shareholders rather well.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool October 4, 2005 Nathan Parmelee	Deceptive Free Cash Flow Free cash flow is a great metric for measuring the cash profitability of a business over time. But it's possible to overestimate it if you don't pay careful attention to details. Here are a few items to check for when analyzing a company's free cash flow.
The Motley Fool January 27, 2006 Stephen D. Simpson	NBTY Makes a U-Turn While the supplement-maker's stock is up about 17%, it still wasn't a great quarter. Investors, take note.
The Motley Fool August 23, 2006 Stephen D. Simpson	Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution.
The Motley Fool January 20, 2009 Anders Bylund	Foolish Forecast: Grab Intuitive Surgical While It's Cheap In advance of earnings let's take a look at how medical robotics maker Intuitive Surgical stacks up against some of its peers and competitors.